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Abstract
To date there are no clear criteria to determine whether a microbe is susceptible to biocides or not. As a starting point for
distinguishing between wild-type and resistant organisms, we set out to determine the minimal inhibitory concentration
(MIC) and minimal bactericidal concentration (MBC) distributions for four common biocides; triclosan, benzalkonium
chloride, chlorhexidine and sodium hypochlorite for 3319 clinical isolates, with a particular focus on Staphylococcus aureus
(N = 1635) and Salmonella spp. (N = 901) but also including Escherichia coli (N = 368), Candida albicans (N = 200), Klebsiella
pneumoniae (N = 60), Enterobacter spp. (N = 54), Enterococcus faecium (N = 53), and Enterococcus faecalis (N = 56). From these
data epidemiological cut-off values (ECOFFs) are proposed. As would be expected, MBCs were higher than MICs for all
biocides. In most cases both values followed a normal distribution. Bimodal distributions, indicating the existence of biocide
resistant subpopulations were observed for Enterobacter chlorhexidine susceptibility (both MICs and MBCs) and the
susceptibility to triclosan of Enterobacter (MBC), E. coli (MBC and MIC) and S. aureus (MBC and MIC). There is a concern on the
potential selection of antibiotic resistance by biocides. Our results indicate however that resistance to biocides and, hence
any potential association with antibiotic resistance, is uncommon in natural populations of clinically relevant
microorganisms.
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Introduction
Biocides have been used extensively for decades and are present
in a wide range of commonly used compounds, including
pesticides, disinfectants, antiseptics, preservatives for food, anti-
fouling products, toothpastes, home-used detergents and even at
some formulations of concrete or textiles among others [1–3]. The
increased use of biocides for an expanding range of applications
have raised concerns on the potential effect their use may have for
human health as well as on the impact on the natural populations
of microorganisms [1,4–6]. In particular, there is growing concern
regarding the possible effect the widespread use of biocides may
have on selection for antibiotic resistance in clinically relevant
microorganisms [7–12]. The fact that many formulations/
products contain biocides at low concentrations and that the
discharge of biocides in natural ecosystems produce a full
landscape of biocide selective concentrations might enhance the
risk of selection of resistant microbes. In 2009, the Scientific
Committee on Emerging and Newly Identified Health Risks
(SCENHIR) produced a report for the European Commission
entitled Assessment of the Antibiotic Resistance Effects of Biocides
(http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/
scenihr_o_021.pdf). In this report, it was stated that ‘biocides are
likely to contribute to maintaining selective pressure allowing the
presence of mobile genetic elements harboring specific genes involved
in the resistance to biocides and antibiotics’. One recommendation of
the SCENHIR report was to have standardized methodologies and
surveillance programs to monitor levels of biocide resistance.
Current methodologies for studying the effect of biocides are
based on the evaluation of the potency of the compound itself for
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killing an organism in a short time lapse. Since the methods are
based on the analysis of the compound and not on the study of the
microorganisms, there is not a clear definition of biocide
resistance. Differing to the situation with most antibiotics where
clinical outcome data, PK/PD models and MIC distributions are
used to determine clinical breakpoints (susceptible, intermediate or
resistant) to guide therapy [13], a similar definition of biocide
resistance, based on breakpoints, is absent. All previous studies
dealing with this topic, compare the MIC (measured using same
methods as those used for antibiotics) of a wild-type strain with
another isolate containing a mutation or a gene presumptively
encoding biocide resistance. If the second is less susceptible than
wild-type, it is considered as resistant. This method can be of value
when the potentially resistant strain derives from the wild-type
one, which is considered as susceptible by definition. However, it is
of no use when natural isolates are studied, because as is stated
above there are not breakpoints to define resistance to biocides
and consequently such isolates cannot be classified as susceptible
or resistant. Consequently, whereas in vitro work on the role of
biocide resistance on the selection of antibiotic resistance has
produced solid results [7,8,14–16], the absence of a definition of
biocide resistance has meant that available epidemiological data in
this respect is extremely limited [4,16].
The aim of the present work is to establish appropriate
breakpoints for defining biocide resistance for those biocides as
triclosan (TRI), benzalkonium chloride (BZC), chlorhexidine
(CHX) and hypochloride for which more concerns on the
potential coselection of antibiotic resistance have been raised.
These breakpoints will be the hallmarks for future studies to define
mechanisms of biocide resistance as well as for analyzing the
potential selection of antibiotic resistance by biocides in natural
isolates. For this purpose, we have made use of the concept of
epidemiological cut-off values (ECOFFs, http://www.eucast.org/
fileadmin/src/media/PDFs/EUCAST_files/EUCAST_Presentations/
2011/EW1_Brown_Definitionsf2.pdf). These breakpoints are not
based, as clinical breakpoints are, on the likelihood of treatment
failure to define resistance, rather ECOFFs are defined on the basis
of the normal distribution of MICs in a given bacterial species. All
isolates which have MICs inside this distribution are considered as
wild-type, and those presenting MICs above this value are
considered as resistant [6]. Reference MIC distributions and
ECOFFs for many microorganism-antibiotic combinations are
collated by the European Committee on Antimicrobial Suscepti-
bility Testing (EUCAST) to help highlight those organisms that may
have acquired resistance mechanisms (http://www.eucast.org/
mic_distributions/).
In this study, therefore, we evaluated MIC distributions for
TRI, BZC, CHX and NaOCl against 3327 clinical isolates
belonging to relevant microbial pathogen species. Minimal
bactericidal/fungicidal concentrations (MBC/MFC) distributions
were also evaluated to take into account the microbicidal
properties of biocides. Based on these distributions, ECOFFs (for
MIC and MBC) are proposed for these biocides to assist future
surveillance of biocide susceptibility and also help discover
potential resistance mechanisms to biocides.
Materials and Methods
Bacterial and Fungal Strains
The following strains were evaluated and came from strain
collections held at Quotient Bioresearch (Fordham, UK), Hospital
Universitario Ramo´n y Cajal (Madrid, Spain) and Gazi University
School of Medicine (Ankara, Turkey). 1635 Staphylococcus aureus
strains collected between 2002 and 2003, from different
geographical origins (world-wide), representing both hospital and
community acquired infections; 901 Salmonella spp. collected
between 1999 and 2003 from European veterinary sources; 368
Escherichia coli collected between 1998 and 2011 from Spain; 200
Candida albicans collected in 2010 and 2011 from hospital acquired
infections and vulvovaginal candidiasis in Turkey; 50 Klebsiella
pneumoniae collected between 1991 and 2011 from Spain; 53
Enterococcus faecium collected between 1986 and 2009 from world-
wide locations; 56 Enterococcus faecalis collected between 2001 and
2009 from Spain and 54 Enterobacter spp. collected between
1991–2011 from Spain.
Biocides
Stock solutions of Benzalkonium chloride (BZC; Sigma, B6295)
and Chlorhexidine digluconate (CHX; Sigma, C9394) were
prepared in sterile distilled water at a concentration of 100 mg/
ml prior to further dilution in broth and distribution into 96-well
plates. Stock solutions of triclosan (TRI; Irgasan; Sigma 72779)
were prepared at 400 mg/L in methanol and a dilution series at
100x final concentration prepared in methanol prior to 1:100
dilution in broth in 96-well plates. Sodium hypochlorite (Sigma,
425044) was prepared in sterile distilled water at a concentration
range between 0.128–65 g/L at serial dilutions in 96-well plates.
All solutions were freshly prepared on the day of the experiment
and kept protected from light.
Susceptibility Testing
Minimum inhibitory concentrations (MICs) were determined
using the broth microdilution method set by the Clinical
Laboratory Standards Institute (CLSI) [13]. Determination of
the minimum bactericidal concentrations (MBCs) or minimum
fungicidal concentrations (MFCs) were performed by subculturing
10 ml from each well without visible microbial growth. After 48
hours of incubation the biocide dilution yielding three colonies or
less was scored as the MBC/MFC as described by the CLSI for
starting inocula of 16105 CFU/ml [14].
Determination of ECOFFs
Where unimodal MIC or MBC/MFC distributions were shown
ECOFFs were determined as concentrations representing$99.9%
of the bacterial population (MIC99.9, MBC99.9 or MFC99.9), as
described previously [15]. If the distribution was bimodal the
ECOFF was set between the two populations.
Results and Discussion
To date there are no clear criteria to determine whether a given
microbe non-susceptible to biocides or not. Even in the case of
antibiotic resistance, different definitions have been proposed [17].
As stated by EUCAST (http://www.eucast.org/fileadmin/src/
media/PDFs/EUCAST_files/EUCAST_Presentations/2011/EW1_
Brown_Definitionsf2.pdf), from the clinical point of view ‘‘a
microorganism is defined as susceptible by a level of antimicrobial
activity associated with a high likelihood of therapeutic success’’ and
‘‘a microorganism is defined as resistant by a level of antimicrobial
activity associated with a high likelihood of therapeutic failure’’.
These operational definitions of resistance do not discriminate
between wild-type organisms and those that have acquired low-level
resistance to antibiotics if the MICs achieved still categorize these
bacteria as susceptible. In the case of biocides, these definitions are
not useful, because these compounds are frequently used at surfaces,
where their concentrations can be much higher than in the case of
therapeutic agents, for which toxicity and pharmacodynamics
constrain the actual concentrations faced by the microorganisms
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Figure 1. Populational susceptibility to biocides of different pathogens: To analyze the overall susceptibility to the studied biocides, the
MICs and MBCs (MFCs in the case of Candida) of several independent isolates were established. The name of the studied biocide is displayed in each
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during treatment. As the consequence of this situation there is not
currently any operational definition of resistance in the case of
biocides, which makes difficult performing meaningful epidemio-
logical analysis on biocide resistance in natural bacterial isolates.
Furthermore, comparing results from different studies is also made
very difficult.
In order to discuss biocide resistance, we require a more suited
definition, one which is based on the ‘‘natural’’ susceptibility to
antimicrobials of a given species and not just on the clinical success of
the treatment. This ecological concept of resistance states that ‘‘a
microorganism is defined as wild type for a species by the absence of
acquired and mutational mechanisms of resistance to the agent’’
(http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/
EUCAST_Presentations/2011/EW1_Brown_Definitionsf2.pdf). The
definition of the wild-type MIC phenotype is obtained by the study
of several unrelated isolates, which allow establishing the epidemi-
ological cut-off value (ECOFF), which is the upper limit of the
normal MICs distribution for a given antimicrobial and a given
species. Any isolate presenting a MIC above this value is considered
as resistant irrespective of whether or not the achieved level of
resistance compromises therapy.
As a starting point for distinguishing between wild-type and
resistant organisms, we set out to determine the distributions of the
MICs and the MBCs of TRI, BZC, CHX and NaOCl for natural
isolates of different relevant pathogens. We name ‘‘natural
isolates’’ as those that have been isolated from any habitat
(including infection), but have not been sub-cultured for several
generations under laboratory-growing conditions. The tested
organisms included ‘‘bacterial species submitted to selective pressure,
involved in the transmission of MGE and directly involved in the biological
hazard (final host)’’ as recommended by the Scientific Committee on
Emerging and Newly Identified Health Risks (SCENIHR;
http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/
scenihr_o_021.pdf Among them, we focused on isolates representing
main clonal lineages and mobile genetic elements involved in spread
of antibiotic resistance (Enterobacteriaceae, Enterococci) and isolates of
foodborne and zoonotic pathogens (S. aureus, Salmonella). Candida
isolates were also included as representative of fungi of medical and
veterinary relevance. To avoid over-representation of epidemic
clones that could produce a bias on the studied bacterial populations,
isolates had different geographical and/or temporal origins. As
would be expected, MBCs were higher than MICs for all biocides
and in most cases both values followed a normal distribution
(Figure 1), with some few exceptions that will be discussed later on.
This type of MIC distribution is the expected one for non-biased
bacterial populations, which indicates that our samples are
appropriate for defining MIC and MBC ECOFF values for the
tested biocides and populations. Using this information, MIC50/
MBC50 and MIC90/MBC90 values for each of the analyzed species
were determined (Table 1) as well as the MIC and MBC ECOFF
values (Table 2). As shown in the Table 1 and Figure 1, S. aureus was
the most susceptible species to all tested biocides and Enterococci the
least susceptible organism group for TRI, CHX and NaOCl,
whereas K. pneumoniae, E. coli, Salmonella and Enterobacter spp.,
presented the lowest susceptibilities to BZC.
In the cases in which the ECOFFs for antibiotics have been
studied, the MICs of the populations frequently follow bimodal of
even multimodal distributions. These distributions indicate the
existence of different subpopulations, each one with a different
level of susceptibility due to the presence of specific mechanisms of
resistance. In this current study, bimodal distributions were
uncommon and observed for just Enterobacter CHX susceptibility
(both MICs and MBCs), TRI susceptibility to of Enterobacter
(MBC), E. coli (MBC and MIC) and S. aureus (MBC and MIC). For
S. aureus those with high TRI MBC were found all to harbor either
a mutated fabI gene, a mutation in the fabI promoter or an added
fabI gene [18]. None of the screened phenotypically susceptible
strains harbored any of these markers [18]. This indicates that
panel. In all cases the upper graph shows the MICs distributions and the lower one the MBCs distributions. TRI, CHX and BZC, concentration as
expressed in mg/L. For Nalco concentration is expressed as g/L of active chlorine.
doi:10.1371/journal.pone.0086669.g001
Table 1. MIC50 and MIC90 of four common biocides for 3327 microbial isolates.
Species Na TRI
b CHXb BZCb NaOClb
MIC (0.015–
128)c
MBC (0.015–
512)c
MIC (0.5–
64)c
MBC (0.5–
64)c
MIC (0.5–
128)c
MBC (0.5–
128)c
MIC (0.125–
32)
MBC (0.125–
32)
50 90 50 90 50 90 50 90 50 90 50 90 50 90 50 90
Salmonella
spp.
901 0.06 0.12 1 2 32 64 64 64 16 16 16 32 2 2 2 4.1
E. coli 368 0.12 0.5 1 4 4 16 8 16 16 32 16 32 4.1 4.1 8.2 8.2
K.
pneumoniae
60 0.12 1 1 2 8 32 8 .32 8 16 8 16 8.2 8.2 8.2 8.2
Enterobacter
spp.
54 0.12 0.5 1 2 8 64 8 64 16 32 32 64 4.1 4.1 4.1 4.1
S. aureus 1635 0.03 0.06 0.12 0.25 2 4 4 8 2 4 2 4 1 2 2 4.1
E. faecium 53 8 8 16 16 8 16 16 32 4 8 4 8 8.2 8.2 8.2 16.4
E. faecalis 56 8 8 16 16 32 32 32 64 2 4 8 8 4.1 8.2 4.1 8.2
C. albicans 200 4 8 8 8 8 8 8 16 4 4 8 16 4.1 4.1 4.1 8.2
aN: number of strains.
bTRI, CHX and BZC, concentration as expressed in mg/L. For NaOCl concentration is expressed as g/L of active chlorine.
cRange of tested concentrations. TRI, CHX and BZC, concentration as expressed in mg/L. For NaOCl concentration is expressed as g/L of active chlorine.
doi:10.1371/journal.pone.0086669.t001
Analysis of Biocide Resistance Based on ECOFFs
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e86669
TRI resistance is due to either changes in the in-host FabI, either
to the acquisition of a second fabI copy in the case of S. aureus.
None of these TRI resistance mechanisms correlates with an
increase in antibiotic resistance. Enterobacteriaceae were tested for
genes previously associated with biocide resistance (qac, acrAB,
fabI). Surprisingly, reduced susceptibility to BZC was not linked to
the presence of qac genes qacI, qacE and qacK despite these genes
appear in 5–20% of the E. coli isolates analyzed. Similarly to the
situation observed for S. aureus, changes in the fabI sequences were
noted for E. coli isolates with reduced susceptibility to TRI (TC
et al. to be published).
For all other combinations of biocides and micro-organisms,
modal distributions, reflecting the lack of clearly resistant
subpopulations, were found (Figures 2, 3, 4, 5). This is particular
cumbersome in the case of qac genes, which are present in widely
distributed integrons or plasmids and for which a role on resistance
to benzalkonium chloride, and hence on co-selection of resistance
determinants present in the mobile elements have been proposed
[19,20]. Bimodal distributions, reflecting the presence of qac genes
may be predicted. However, these distributions were not found
and a correlation between the presence of qac determinants and a
clear increase in resistance was not fully evident when analyzed
([21], TC et al. unpublished). It is worth mentioning that most
contemporary studies in this topic are based on correlation
analysis on the abundance of integrons containing qac genes on
contaminated and non-contaminated environments; and not on
the phenotype of susceptibility to biocides of the overall microbial
populations. Since contaminated ecosystems frequently harbor
several different pollutants, including antibiotics, it is difficult to
ascertain which is the selective force that selects bacteria carrying
integrons in such environments. In this regard, two recent articles
indicate that the actual effect of qac genes on resistance to
quaternary ammonium compounds may be low [22], although
they can reduce significantly the susceptibility to other compounds
as ethidium bromide that are not used as biocides These results
would seem to cast doubts on the actual role that quaternary
ammonium-based biocides may have on selection of bacteria
carrying integrons containing qac and antibiotic resistance genes.
Although our results do not preclude the existence of resistant
isolates that can be found if more isolates are analyzed, they show
that the prevalence of these biocide resistant subpopulations in
natural microbial populations is low.
The absence of MIC multimodal distributions indicate that, in
sharp contrast with the situation observed for antibiotics, there is
no clear evidence that the use of biocides have consistently selected
resistant subpopulations presenting MICs above wild-type values,
at least by using classical double dilution susceptibility tests. There
is an exception to this however; in the case of S. aureus susceptibility
to TRI a mechanism of resistance acquired by horizontal gene
transfer, and rendering a bimodal distribution of triclosan
susceptibility, has been recently described [18]. In any case, it is
important to mention that TRI resistance in S. aureus is due to the
heterologous duplication of the gene fabI, which encodes the TRI
target, and this duplication did not affect the susceptibility to
antibiotics currently in use at clinics.
To the best of our knowledge, this is the largest analysis on
biocide MICs or MBCs and the only one to determine ECOFFs
for biocides. These data provide a baseline to measure biocide
susceptibility to assist with future surveillance studies. The finding
that in most cases, we did not find bimodal distributions indicates
the lack of a relevant percentage of biocide resistant isolates at
natural populations. If biocide resistant mutants are rare, this
would imply that co-selection or cross-selection of antibiotic
resistance should also be a rare event in natural populations.
Nevertheless, two other issues must be taken into consideration.
Firstly, most biocides have been widely used for decades; the fact
that we did not find bimodal MIC/MBC distributions in current
populations may reflect the lack of resistance but also a full
replacement of susceptible microorganisms by more resistant ones.
This situation that has been named as MIC-creep, which can be
defined as ‘‘the constant rise over time in the basal intrinsic
resistance of an average isolate of a given bacterial species [23]’’
has been described for different antibiotics [24,25]. Secondly, our
analysis reflects the current steady state of the overall susceptibility
to biocides of the studied microbial populations. These observed
distributions are the consequence of the emergence of resistance,
but also of its spread and stability, the latter being mainly
dependent on the fitness costs associated to the acquisition of
resistance [26–29]. As stated above, several recent studies have
shown that microorganisms can evolve to acquire biocide
resistance, which in several cases, may be associated to resistance
to antibiotics [7,8,14–16]. Although careful studies on this issue
are still scarce [30], it is possible that the stability of these
‘potential’ mechanisms of resistance is impeded by the fitness costs
they confer [31]. However, if these mutants are selected at a
clinical setting and infect a patient before they are outcompeted by
wild-type populations, they can be still a risk for antibiotic therapy.
Table 2. MIC and MBC ECOFFs of four common biocides for 3327 microbial isolates.
Species N* TRI** CHX** BZC** NaOCl**
MIC MBC MIC MBC MIC MBC MIC MBC
Salmonella spp. 901 8 128 32 .64 128 .128 4.1 8.2
E. coli 368 2 16 64 .64 64 128 8.2 16.4
K. pneumoniae 60 2 8 64 64 32 32 8.2 8.2
Enterobacter spp. 54 1 4 16 16 32 64 4.1 8.2
S. aureus 1635 0.5 2 8 .64 16 32 4.1 8.2
E. faecium 53 32 64 32 64 8 16 8.2 16.4
E. faecalis 56 16 32 64 .64 8 16 8.2 8.2
C. albicans 200 16 16 16 32 16 32 8.2 16.4
*N: number of strains.
**TRI, CHX and BZC, concentration as expressed in mg/L. For NaOCl concentration is expressed as g/L of active chlorine.
doi:10.1371/journal.pone.0086669.t002
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Figure 2. Populational susceptibility to triclosan of different pathogens: To analyze the overall susceptibility to triclosan, the MICs and
MBCs (MFCs in the case of Candida) of several independent isolates were established. Blue bars MICs, green bars MBCs/MFCs. ECOFFs are shown with
arrows of the corresponding colour.
doi:10.1371/journal.pone.0086669.g002
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Figure 3. Populational susceptibility to chlorhexidine of different pathogens: To analyze the overall susceptibility to chlorehexidine, the
MICs and MBCs (MFCs in the case of Candida) of several independent isolates were established. Blue bars MICs, green bars MBCs/MFCs. ECOFFs are
shown with arrows of the corresponding colour.
doi:10.1371/journal.pone.0086669.g003
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Figure 4. Populational susceptibility to benzalkonium chloride of different pathogens: To analyze the overall susceptibility to
benzalkonium chloride, the MICs and MBCs (MFCs in the case of Candida) of several independent isolates were established. Blue bars MICs, green
bars MBCs/MFCs. ECOFFs are shown with arrows of the corresponding colour.
doi:10.1371/journal.pone.0086669.g004
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Figure 5. Populational susceptibility to hypochloride of different pathogens: To analyze the overall susceptibility to hypochloride, the MICs
and MBCs (MFCs in the case of Candida) of several independent isolates were established. Blue bars MICs, green bars MBCs/MFCs. ECOFFs are shown
with arrows of the corresponding colour. Concentration of NaOCl is expressed as active chlorine.
doi:10.1371/journal.pone.0086669.g005
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